Ventrus Biosciences, Inc.  (VTUS) to Present at Upcoming Investor Conferences in September  
8/29/2012 9:20:21 AM

NEW YORK, Aug. 29, 2012 (GLOBE NEWSWIRE) -- Ventrus Biosciences, Inc. (Nasdaq:VTUS) a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that Dr. Russell Ellison, Chairman and Chief Executive Officer, will be presenting at the following upcoming investor conferences during the month of September 2012.